CD8A and bacterial infectious disease: Thus, it may be possible to limit or differentially modulate NKp46 receptor ligation and resultant NK cell activation during vaccination with live attenuated viruses in order to enhance protective CD8+ TRM development, limiting respiratory immunopathology and susceptibility to secondary bacterial infection after re-challenge.